Transfusion Reaction

• 

  Subject Areas on Research

  • A randomized study comparing leukocyte-depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients. 
  • Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study. 
  • Acquired peanut hypersensitivity after transfusion. 
  • Acute coronary syndromes: Blood transfusion in patients with acute MI and anaemia. 
  • Allogeneic leukocytes but not therapeutic blood elements induce reactivation and dissemination of latent human immunodeficiency virus type 1 infection: implications for transfusion support of infected patients. 
  • Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival. 
  • Alternate analysis strategies for retrospective assessment of outcomes with a male donor-only plasma policy. 
  • Anaphylactic/anaphylactoid reactions during cardiac surgery. 
  • Anemia and blood transfusion in trauma patients admitted to the intensive care unit. 
  • Anti-Jka that are detected by solid-phase red blood cell adherence but missed by gel testing can cause hemolytic transfusion reactions. 
  • Anti-N and anti-Doa immunoglobulin G alloantibody-mediated delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease treated with eculizumab and HBOC-201: case report and review of the literature. 
  • Antibody-coated erythrocytes induce secretion of tumor necrosis factor by human monocytes: a mechanism for the production of fever by incompatible transfusions. 
  • Antithrombin deficiency increases thrombin activity after prolonged cardiopulmonary bypass. 
  • Assessing the safety and efficacy of a test-based, targeted donor screening strategy to minimize transfusion transmitted malaria. 
  • Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End-Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization-An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program. 
  • Bacterial contamination of platelets for transfusion: strategies for prevention. 
  • Bedside Allogeneic Erythrocyte Washing with a Cell Saver to Remove Cytokines, Chemokines, and Cell-derived Microvesicles. 
  • Blood Products in the Management of Abnormal Placentation. 
  • Blood transfusion after percutaneous coronary intervention and risk of subsequent adverse outcomes: a systematic review and meta-analysis. 
  • Blood transfusion in trauma patients: unresolved questions. 
  • Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. 
  • Bye-bye TRALI: by understanding and innovation. 
  • Cancer- and chemotherapy-induced anemia. 
  • Captopril-enhanced binding of PlA1 (HPA-1a) antibodies in posttransfusion purpura. 
  • Carboxyhemoglobin levels in banked blood. 
  • Coagulopathy is prevalent and associated with adverse outcomes in transfused pediatric trauma patients. 
  • Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components. 
  • Complications of hysterectomy in women with von Willebrand disease. 
  • Concepts of blood transfusion in adults. 
  • Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. 
  • Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay. 
  • Development of a multisystem surveillance database for transfusion-transmitted infections among blood donors in the United States. 
  • Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. 
  • Disseminated intravascular coagulation and renal failure: Production in the monkey with autologous red blood cell stroma. 
  • Effect of Antifibrinolytic Therapy on Complications, Thromboembolic Events, Blood Product Utilization, and Fusion in Adult Spinal Deformity Surgery. 
  • Effects of ABO Matching of Platelet Transfusions in Critically Ill Children. 
  • Evaluation of amotosalen and UVA pathogen-reduced apheresis platelets after 7-day storage. 
  • Giving TRALI the one-two punch. 
  • HTLV-III seroconversion associated with heat-treated factor VIII concentrate. 
  • Hemolytic transfusion reactions caused by failure of commercial antiglobulin reagents to detect complement. 
  • Hepatitis C infection in children with hemophilia A and B. 
  • Hepato-biliary late effects in survivors of childhood and adolescent cancer: a report from the Children's Oncology Group. 
  • High-dose intravenous immunoglobulin for severe platelet alloimmunization. 
  • How do we manage blood donors and recipients after a positive Zika screening result? 
  • Impact of hydroxyurea on perioperative management and outcomes in children with sickle cell anemia. 
  • Implementation of a pediatric trauma massive transfusion protocol: one institution's experience. 
  • Isoantibody specificity in post-transfusion purpura. 
  • Knowledge of hepatitis C virus screening in long-term pediatric cancer survivors: a report from the Childhood Cancer Survivor Study. 
  • Leukocyte phenotypic changes in an in vitro model of ABO hemolytic transfusion reaction. 
  • Leukocyte-reduced blood transfusions: perioperative indications, adverse effects, and cost analysis. 
  • Management of surgical hemostasis: systemic agents. 
  • Managing clotting: a North American perspective. 
  • Many, but not all, outcome studies support exclusion of female plasma from the blood supply. 
  • Medical chart validation of inpatient diagnosis codes for transfusion-related acute lung injury 2013-2015. 
  • Microparticles from stored red blood cells promote a hypercoagulable state in a murine model of transfusion. 
  • Non-A, non-B hepatitis and chronic dialysis--another dilemma. 
  • Noninfectious transfusion-associated adverse events and their mitigation strategies. 
  • Organ iron accumulation in chronically transfused children with sickle cell anaemia: baseline results from the TWiTCH trial. 
  • Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial. 
  • Perioperative Fresh Red Blood Cell Transfusion May Negatively Affect Recipient Survival After Liver Transplantation. 
  • Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases. 
  • Predicted Risk of Mortality, Transfusion, and Postoperative Outcomes in Isolated Primary Valve Operations. 
  • Prevention and diagnosis of delayed haemolytic transfusion reactions. 
  • Prevention and treatment of coagulopathy in patients receiving massive transfusions. 
  • Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids. 
  • Principles and problems of transfusion in sickle cell disease. 
  • Probable and possible transfusion-transmitted dengue associated with NS1 antigen-negative but RNA confirmed-positive red blood cells. 
  • Proceedings of the Food and Drug Administration's public workshop on new red blood cell product regulatory science 2016. 
  • Risk factors for development of systemic lupus erythematosus: allergies, infections, and family history. 
  • Risk factors for retrovirus and hepatitis virus infections in accepted blood donors. 
  • Seasonal variability is not observed in the rates of high anti-A and anti-B titers in plasma, apheresis platelet, and whole blood units tested by different methods. 
  • Septic risk increases with apheresis platelet storage time. 
  • Spotlight on pathogenesis of TRALI: HNA-3a (CTL2) antibodies. 
  • Successful surgical outcome in children with sickle hemoglobinopathies: the Duke University experience. 
  • Survey of Irradiation Practice for the Prevention of Transfusion-Associated Graft-versus-Host Disease. 
  • Survey on Transfusion-Transmitted Cytomegalovirus and Cytomegalovirus Disease Mitigation. 
  • TRALI by proxy. 
  • The association of rapid volume expansion and intraventricular hemorrhage in the preterm infant. 
  • The selection and evaluation of new chelating agents for the treatment of iron overload. 
  • Transfusion management in sickle cell disease. 
  • Transfusion management of trauma patients. 
  • Transfusion reactions associated with COVID-19 convalescent plasma therapy for SARS-CoV-2. 
  • Transfusion-related acute lung injury: from bedside to bench and back. 
  • Two cases of transfusion-associated graft-vs-host disease after open heart surgery. 
  • Use of a rapid electronic survey methodology to estimate blood donors' potential exposure to emerging infectious diseases: Application of a statistically representative sampling methodology to assess risk in US blood centers. 
  • Vincristine therapy for severe platelet alloimmunization. 
  • Visual loss after spine surgery: a population-based study.